Guizhou Yibai Pharmaceutical Co. Ltd.SSE: 600594

Announcement on Convening the Q3 2025 Performance Briefing

Nov 14, 2025 · Issued by Guizhou Yibai Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 14, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-226

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix

Earlier from Guizhou Yibai Pharmaceutical

Announcement on Election of Employee Representative DirectorNov 11, 2025
Announcement on Resolutions of the 13th Meeting of the 8th Board of DirectorsOct 30, 2025
Announcement on Release of Pledge of Partial Shares of Controlling ShareholdersOct 16, 2025
Announcement on Receipt of the Notice on Lifting the Suspension of Production and Sales from the Guizhou Provincial Medical Products AdministrationSep 18, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 6, 2025

Later from Guizhou Yibai Pharmaceutical

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Nov 27, 2025
Announcement on Pledge and Pledge Release of Some Shares Held by Controlling ShareholderNov 28, 2025
Announcement on Changing Annual Audit Institution’s Signatory Certified Public AccountantDec 6, 2025
Indicative Announcement on Expected Loss in Performance for 2025Jan 13
Earnings Preannouncement for 2025Jan 22

All Guizhou Yibai Pharmaceutical news releases

Follow Guizhou Yibai Pharmaceutical into a list and get an email when it puts out news.

Follow Guizhou Yibai Pharmaceutical